This Toxic Chinese company Must Avoid - Avis employé Director BeOne

1,0
28 janv. 2021
Recommande
Approbation du PDG
Perspective commerciale

Avantages

It's a Chinese company so if you are used to 996 schedule and ready for ICU.

Inconvénients

Management expected long hours of work without any compensation, including weekends. Most of their products were licensed from approved US drugs and being manufactured in China. Competed out US drug companies with Chinese government incentive. All manufacturing occurred in China, and it was forced tech transferred from the license companies. No true value in core.

Découvrez plus d’avis sur BeOne

5,0
24 avr. 2026
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Inconvénients

Fast timelines and global expansion may translate into heavy workload and urgency

3,0
5 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good wprk tee lunch and free commute

Inconvénients

Bad work but bad commute to work

Voir les avis par: Utile|Évaluation|Date|Tout